INS and Impaired glucose tolerance: On the other hand, BCH treatment significantly improved HF/HFr-induced impaired glucose tolerance at all-time points (0.5, 1, and 2 h) (Fig. 7c) and also restored increased level of fasting plasma insulin in HF/HFr-fed mice to that in control diet (Fig. 7d).